A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily
Clinical trial NCT04983589 · COMPLETED
Trial details
- NCT number
- NCT04983589
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-02
- Primary completion
- 2022-02-11
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.